Cytotoxic and antitumor properties of methionine γ-lyase conjugate in combination with S-alk(en)yl–L-cysteine sulfoxides

Background. Enzyme prodrug therapy is a promising strategy to treat solid malignancies. The utilization of two-component systems, including an enzyme and a non-toxic prodrug, to generate cytotoxic compounds directly at the surface of the tumor cell can be successful strategy in reducing the overall toxic load on the body.

Aim. To determine antitumor activity of the pharmacological pair C115H methionine γ-lyase (C115H MGL) conjugated with daidzein (C115H MGL-Dz) and of S-alk(en)yl-L-cysteine sulfoxides against various types of solid tumors in vitro and in vivo.

Materials. MTT-test was used to determine the cytotoxicity of C115H MGL-Dz in the presence of S-alk(en)yl-L-cysteine sulfoxides in vitro against Sw620 (colon cancer), Panc1 (pancreatic cancer), and 22Rv1 (prostate cancer). Apopto- sis induction and cell cycle alteration in 22Rv1, Sw620, and SKBR3 cell lines were studied using the Muse® Caspase-3/7 and Muse® Cell Cycle Assay kits. In vivo anticancer activity was studied on Sw620, Panc1, and 22Rv1 subcutaneous xenografts in Balb/c nude mice.

Results. The C115H MGL-Dz had the maximum cytotoxic activity in the presence of S-propyl-L-cysteine sulfoxide (propiin) with IC₅₀ values: 3.88 and 5.4 for Panc1 and 22Rv1, respectively. Dipropyl thiosulfinate formed by the β-eli-mination of propiin catalyzed by C115H MGL-Dz, induces apoptosis through both the activation of caspases and alternative pathways, and also it inhibits cell division, contributing to a decrease in the concentration of cells in the G₂/M phase. The anticancer efficacy of the pharmacological pair C115H-Dz/propiin in vivo indicated a significant decrease in Panc1 tumor volume (tumor growth inhibition (TGI) 67.5 %, p = 0.004), Sw620 (TGI 22.07 %, p = 0.12) and 22Rv1 (TGI 70 %, p = 0.043).

Conclusion. Pharmacological pair C115H MGL-Dz/propiin was capable of suppressing tumor development in malignant solid tumors and might be considered as a potential anticancer approach in cancer prodrug therapy.

1. Henderson B.E., Ross R.K., Pike M.C., Casagrande J.T. Endogenous hormones as a major factor in human cancer. Cancer Res 1982;42(8):3232–9.

2. Tanaka H., Esaki N., Soda K. A versatile bacterial enzyme: l-methionine γ-lyase. Enzyme Microb Technol 1985;7(11): 530–7. DOI: 10.1016/0141-0229(85)90094-8

3. Morozova E., Anufrieva N., Koval V. et al. Conjugates of methionine γ-lyase with polysialic acid: two approaches to antitumor therapy. Int J Biol Macromol 2021;182:394–401. DOI: 10.1016/j.ijbiomac.2021.03.201

4. Fujisawa H., Watanabe K., Suma K. et al. Antibacterial potential of garlic-derived allicin and its cancellation by sulfhydryl compounds. Biosci Biotechnol Biochem 2009;73(9):1948–55. DOI: 10.1271/bbb.90096

5. Weber N.D., Andersen D.O., North J.A. et al. In vitro virucidal effects of Allium sativum (garlic) extract and compounds. Planta Med 1992;58(5):417–23. DOI: 10.1055/s-2006-961504

6. Hoffman R.M. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther 2015;15(1):21–31. DOI: 10.1517/14712598.2015.963050

7. Pokrovsky V.S., Anisimova N.Yu., Davydov D.Zh. et al. Methionine gamma lyase from Clostridium sporogenes increases the anticancer effect of doxorubicin in A549 cells and human cancer xenografts. Invest New Drugs 2019;37(2):201–9. DOI: 10.1007/s10637-018-0619-4

8. Filardo E.J., Quinn J.A., Frackelton A.R.J., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol 2002;16(1):70–84. DOI: 10.1210/mend.16.1.0758

9. Mesmar F., Dai B., Ibrahim A. et al. Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling. Cancer Med 2019;8(18):7705–19. DOI: 10.1002/cam4.2581

10. Ariyani W., Miyazaki W., Amano I. et al. Soy isoflavones accelerate glial cell migration via GPER-mediated signal transduction pathway. Front Endocrinol (Lausanne) 2020;11:554941. DOI: 10.3389/fendo.2020.554941

11. Jacenik D., Beswick E.J., Krajewska W.M., Prossnitz E.R. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis. World J Gastroenterol 2019;25(30):4092–104. DOI: 10.3748/wjg.v25.i30.4092

12. Chan Q.K.Y., Lam H.-M., Ng C.-F. et al. Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrest. Cell Death Differ 2010;17(9):1511–23. DOI: 10.1038/cdd.2010.20

13. Sarkar F.H., Li Y. Soy isoflavones and cancer prevention. Cancer Invest 2003;21(5):744–57. DOI: 10.1081/CNV-120023773

14. Morozova E.A., Kulikova V.V., Rodionov A.N. et al. Engineered Citrobacter freundii methionine γ-lyase effectively produces antimicrobial thiosulfinates. Biochimie 2016;128–129:92–8. DOI: 10.1016/j.biochi.2016.07.007

15. Kulikova V., Morozova E., Rodionov A. et al. Non-stereoselective decomposition of (±)-S-alk(en)yl-L-cysteine sulfoxides to antibacterial thiosulfinates catalyzed by C115H mutant methionine γ-lyase from Citrobacter freundii. Biochimie 2018;151:42–4. DOI: 10.1016/j.biochi.2018.05.011

16. Kulikova V.V., Morozova E.A., Revtovich S.V. et al. Gene cloning, characterization, and cytotoxic activity of methionine γ-lyase from Clostridium novyi. IUBMB Life 2017;69(9):668–76. DOI: 10.1002/iub.1649

17. Morozova E.A., Bazhulina N.P., Anufrieva N.V. et al. Kinetic and spectral parameters of interaction of Citrobacter freundii methionine γ-lyase with amino acids. Biochemistry (Mosc) 2010;75(10):1272–80. DOI: 10.1134/S0006297910100093

18. Kohen F., Gayer B., Kulik T. et al. Synthesis and evaluation of the antiproliferative activities of derivatives of carboxyalkyl isoflavones linked to N-t-Boc-hexylenediamine. J Med Chem 2007;50(25):6405–10. DOI: 10.1021/jm070727z

19. Bank U., Reinhold D., Ansorge S. [Measurement of cellular activity with the MTT test. Optimization of the method (In German)]. Allerg Immunol (Leipz) 1991;37(3–4):119–23.